Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26F9P0Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,510
Award facts
- Contract value 100% obligated
- $43,509.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $43,509.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, which is not set-aside and was competitively awarded, carries an ultimate completion date of November 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military and federal healthcare systems globally.
AmerisourceBergen, a major pharmaceutical distributor and critical federal medical vendor, regularly fulfills pharmaceutical procurement requirements across the Defense Logistics Agency's Medical Supply Chain. Enbrel, a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune conditions, is among the specialized pharmaceutical products the company supplies to support military healthcare programs. The IDC vehicle under which this award falls enables the Defense Logistics Agency to procure a broad range of pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency and other federal healthcare customers worldwide.
Quick answers
Who was awarded contract SPE2DR26F9P0Q?
SPE2DR26F9P0Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F9P0Q worth?
The government has obligated $43,510 on SPE2DR26F9P0Q.
Is contract SPE2DR26F9P0Q an order under another contract?
Yes. SPE2DR26F9P0Q is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9P0Q competed?
The extent of competition for SPE2DR26F9P0Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award